Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 14 March 1986:
Vol. 231. no. 4743, pp. 1289 - 1291
DOI: 10.1126/science.2418504
Prev | Table of Contents | Next

Articles

Science, Vol 231, Issue 4743, 1289-1291
Copyright © 1986 by American Association for the Advancement of Science

articles

Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV

F di Marzo Veronese, TD Copeland, AL DeVico, R Rahman, S Oroszlan, RC Gallo, and MG Sarngadharan

Approximately 80 percent of all human sera that react with antigens of HTLV-III, the etiologic agent of the acquired immune deficiency syndrome (AIDS), recognize protein bands at 66 and 51 kilodaltons. A mouse hybridoma was produced that was specific to these proteins. Repeated cloning of the hybridoma did not separate the two reactivities. The p66/p51 was purified from HTLV-III lysates by immunoaffinity chromatography and subjected to NH2-terminal Edman degradation. Single amino acid residues were obtained in 17 successive degradation cycles. The sequence determined was a perfect translation of the nucleotide sequence of a portion of the HTLV-III pol gene. The purified p66/51 had reverse transcriptase activity and the monoclonal immunoglobulin G specifically removed the enzyme activity from crude viral extract as well as purified enzyme.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
A New Generation of Peptide-based Inhibitors Targeting HIV-1 Reverse Transcriptase Conformational Flexibility.
A. Agopian, E. Gros, G. Aldrian-Herrada, N. Bosquet, P. Clayette, and G. Divita (2009)
J. Biol. Chem. 284, 254-264
   Abstract »    Full Text »    PDF »
Reverse transcription of the HIV-1 pandemic.
A. Basavapathruni and K. S. Anderson (2007)
FASEB J 21, 3795-3808
   Abstract »    Full Text »    PDF »
Sequence, Distance, and Accessibility Are Determinants of 5'-End-directed Cleavages by Retroviral RNases H.
S. J. Schultz, M. Zhang, and J. J. Champoux (2006)
J. Biol. Chem. 281, 1943-1955
   Abstract »    Full Text »    PDF »
Analysis of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Subunit Structure/Function in the Context of Infectious Virions and Human Target Cells.
A. Mulky and J. C. Kappes (2005)
Antimicrob. Agents Chemother. 49, 3762-3769
   Abstract »    Full Text »    PDF »
Mutations That Abrogate Human Immunodeficiency Virus Type 1 Reverse Transcriptase Dimerization Affect Maturation of the Reverse Transcriptase Heterodimer.
J. Wapling, K. L. Moore, S. Sonza, J. Mak, and G. Tachedjian (2005)
J. Virol. 79, 10247-10257
   Abstract »    Full Text »    PDF »
Ordered Processing of the Human Immunodeficiency Virus Type 1 GagPol Precursor Is Influenced by the Context of the Embedded Viral Protease.
S. C. Pettit, J. C. Clemente, J. A. Jeung, B. M. Dunn, and A. H. Kaplan (2005)
J. Virol. 79, 10601-10607
   Abstract »    Full Text »    PDF »
Effects of Mutations in the G Tract of the Human Immunodeficiency Virus Type 1 Polypurine Tract on Virus Replication and RNase H Cleavage.
J. G. Julias, M. J. McWilliams, S. G. Sarafianos, W. G. Alvord, E. Arnold, and S. H. Hughes (2004)
J. Virol. 78, 13315-13324
   Abstract »    Full Text »    PDF »
Subunit-Specific Analysis of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase In Vivo.
A. Mulky, S. G. Sarafianos, E. Arnold, X. Wu, and J. C. Kappes (2004)
J. Virol. 78, 7089-7096
   Abstract »    Full Text »    PDF »
The Y181C Substitution in 3'-Azido-3'-deoxythymidine-resistant Human Immunodeficiency Virus, Type 1, Reverse Transcriptase Suppresses the ATP-mediated Repair of the 3'-Azido-3'-deoxythymidine 5'-Monophosphate-terminated Primer.
B. Selmi, J. Deval, K. Alvarez, J. Boretto, S. Sarfati, C. Guerreiro, and B. Canard (2003)
J. Biol. Chem. 278, 40464-40472
   Abstract »    Full Text »    PDF »
Mutations in the 5' End of the Human Immunodeficiency Virus Type 1 Polypurine Tract Affect RNase H Cleavage Specificity and Virus Titer.
M. J. McWilliams, J. G. Julias, S. G. Sarafianos, W. G. Alvord, E. Arnold, and S. H. Hughes (2003)
J. Virol. 77, 11150-11157
   Abstract »    Full Text »    PDF »
A positively charged side chain at position 154 on the {beta}8-{alpha}E loop of HIV-1 RT is required for stable ternary complex formation.
B. Sharma, N. Kaushik, A. Upadhyay, S. Tripathi, K. Singh, and V. N. Pandey (2003)
Nucleic Acids Res. 31, 5167-5174
   Abstract »    Full Text »    PDF »
Substrate Requirements for Secondary Cleavage by HIV-1 Reverse Transcriptase RNase H.
M. Wisniewski, Y. Chen, M. Balakrishnan, C. Palaniappan, B. P. Roques, P. J. Fay, and R. A. Bambara (2002)
J. Biol. Chem. 277, 28400-28410
   Abstract »    Full Text »    PDF »
The role of template-primer in protection of reverse transcriptase from thermal inactivation.
G. F. Gerard, R. J. Potter, M. D. Smith, K. Rosenthal, G. Dhariwal, J. Lee, and Deb. K. Chatterjee (2002)
Nucleic Acids Res. 30, 3118-3129
   Abstract »    Full Text »    PDF »
Walleye dermal sarcoma virus reverse transcriptase is temperature sensitive.
S. K. Fodor and V. M. Vogt (2002)
J. Gen. Virol. 83, 1361-1365
   Abstract »    Full Text »    PDF »
Characterization of the Protease of a Fish Retrovirus, Walleye Dermal Sarcoma Virus.
S. K. Fodor and V. M. Vogt (2002)
J. Virol. 76, 4341-4349
   Abstract »    Full Text »    PDF »
Ty3 Integrase Is Required for Initiation of Reverse Transcription.
M. H. Nymark-McMahon, N. S. Beliakova-Bethell, J.-L. Darlix, S. F. J. Le Grice, and S. B. Sandmeyer (2002)
J. Virol. 76, 2804-2816
   Abstract »    Full Text »    PDF »
Replication of Phenotypically Mixed Human Immunodeficiency Virus Type 1 Virions Containing Catalytically Active and Catalytically Inactive Reverse Transcriptase.
J. G. Julias, A. L. Ferris, P. L. Boyer, and S. H. Hughes (2001)
J. Virol. 75, 6537-6546
   Abstract »    Full Text »
From the Cover: Nonnucleoside reverse transcriptase inhibitors are chemical enhancers of dimerization of the HIV type 1 reverse transcriptase.
G. Tachedjian, M. Orlova, S. G. Sarafianos, E. Arnold, and S. P. Goff (2001)
PNAS 98, 7188-7193
   Abstract »    Full Text »    PDF »
Recombinant p51 as Antigen in an Immune Complex Transfer Enzyme Immunoassay of Immunoglobulin G Antibody to Human Immunodeficiency Virus Type 1.
K. Hashinaka, S. Hashida, I. Nishikata, A. Adachi, S. Oka, and E. Ishikawa (2000)
Clin. Vaccine Immunol. 7, 967-976
   Abstract »    Full Text »    PDF »
Comparison of Second-Strand Transfer Requirements and RNase H Cleavages Catalyzed by Human Immunodeficiency Virus Type 1 Reverse Transcriptase (RT) and E478Q RT.
C. S. Snyder and M. J. Roth (2000)
J. Virol. 74, 9668-9679
   Abstract »    Full Text »
Analysis of mutations and suppressors affecting interactions between the subunits of the HIV type 1 reverse transcriptase.
G. Tachedjian, H.-E. G. Aronson, and S. P. Goff (2000)
PNAS 97, 6334-6339
   Abstract »    Full Text »    PDF »
Soluble Rous Sarcoma Virus Reverse Transcriptases alpha , alpha beta , and beta Purified from Insect Cells Are Processive DNA Polymerases That Lack an RNase H 3' right-arrow 5' Directed Processing Activity.
S. Werner and B. M. Wohrl (1999)
J. Biol. Chem. 274, 26329-26336
   Abstract »    Full Text »    PDF »
A New Potent HIV-1 Reverse Transcriptase Inhibitor. A SYNTHETIC PEPTIDE DERIVED FROM THE INTERFACE SUBUNIT DOMAINS.
M. C. Morris, V. Robert-Hebmann, L. Chaloin, J. Mery, F. Heitz, C. Devaux, R. S. Goody, and G. Divita (1999)
J. Biol. Chem. 274, 24941-24946
   Abstract »    Full Text »    PDF »
Functional Analysis of Amino Acid Residues Constituting the dNTP Binding Pocket of HIV-1 Reverse Transcriptase.
D. Harris, N. Kaushik, P. K. Pandey, P. N. S. Yadav, and V. N. Pandey (1998)
J. Biol. Chem. 273, 33624-33634
   Abstract »    Full Text »    PDF »
Structure of a Covalently Trapped Catalytic Complex of HIV-1 Reverse Transcriptase: Implications for Drug Resistance.
H. Huang, R. Chopra, G. L. Verdine, and S. C. Harrison (1998)
Science 282, 1669-1675
   Abstract »    Full Text »
Human T-Cell Leukemia Virus Type 1 Reverse Transcriptase (RT) Originates from the pro and pol Open Reading Frames and Requires the Presence of RT-RNase H (RH) and RT-RH-Integrase Proteins for Its Activity.
B. Trentin, N. Rebeyrotte, and R. Z. Mamoun (1998)
J. Virol. 72, 6504-6510
   Abstract »    Full Text »    PDF »
gag, vif, and nef Genes Contribute to the Homologous Viral Interference Induced by a Nonproducer Human Immunodeficiency Virus Type 1 (HIV-1) Variant: Identification of Novel HIV-1-Inhibiting Viral Protein Mutants.
P. D'Aloja, E. Olivetta, R. Bona, F. Nappi, D. Pedacchia, K. Pugliese, G. Ferrari, P. Verani, and M. Federico (1998)
J. Virol. 72, 4308-4319
   Abstract »    Full Text »    PDF »
An Enzymatically Active Chimeric HIV-1 Reverse Transcriptase (RT) with the RNase-H Domain of Murine Leukemia Virus RT Exists as a Monomer.
H. S. Misra, P. K. Pandey, and V. N. Pandey (1998)
J. Biol. Chem. 273, 9785-9789
   Abstract »    Full Text »    PDF »
Construction and Characterization of a Temperature-Sensitive Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutant.
M. Huang, R. Zensen, M. Cho, and M. A. Martin (1998)
J. Virol. 72, 2047-2054
   Abstract »    Full Text »    PDF »
Binding of RNA template to a complex of HIV-1 reverse transcriptase/primer/template.
B. Canard, R. Sarfati, and C. C. Richardson (1997)
PNAS 94, 11279-11284
   Abstract »    Full Text »    PDF »
The Isolated RNase H Domain of Murine Leukemia Virus Reverse Transcriptase. RETENTION OF ACTIVITY WITH CONCOMITANT LOSS OF SPECIFICITY.
X. Zhan and R. J. Crouch (1997)
J. Biol. Chem. 272, 22023-22029
   Abstract »    Full Text »    PDF »
Kinetic Analysis of Four HIV-1 Reverse Transcriptase Enzymes Mutated in the Primer Grip Region of p66. IMPLICATIONS FOR DNA SYNTHESIS AND DIMERIZATION.
B. M. Wohrl, R. Krebs, S. H. Thrall, S. F. J. Le Grice, A. J. Scheidig, and R. S. Goody (1997)
J. Biol. Chem. 272, 17581-17587
   Abstract »    Full Text »    PDF »
Helix Structure and Ends of RNA/DNA Hybrids Direct the Cleavage Specificity of HIV-1 Reverse Transcriptase RNase H.
C. Palaniappan, G. M. Fuentes, L. Rodríguez-Rodríguez, P. J. Fay, and R. A. Bambara (1996)
J. Biol. Chem. 271, 2063-2070
   Abstract »    Full Text »    PDF »
Interface Peptides as Structure-based Human Immunodeficiency Virus Reverse Transcriptase Inhibitors.
G. Divita, J. G. Baillon, K. Rittinger, J.-C. Chermann, and R. S. Goody (1995)
J. Biol. Chem. 270, 28642-28646
   Abstract »    Full Text »    PDF »
Enzymatic Characterization of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Resistant to Multiple 2`,3`-Dideoxynucleoside 5`-Triphosphates.
T. Ueno, T. Shirasaka, and H. Mitsuya (1995)
J. Biol. Chem. 270, 23605-23611
   Abstract »    Full Text »    PDF »
The Formation of the 2`,5`-Phosphodiester Linkage in the cDNA Priming Reaction by Bacterial Reverse Transcriptase in a Cell-free System.
T. Shimamoto, M. Inouye, and S. Inouye (1995)
J. Biol. Chem. 270, 581-588
   Abstract »    Full Text »    PDF »
Footprint analysis of replicating murine leukemia virus reverse transcriptase.
B. Wohrl, M. Georgiadis, A Telesnitsky, W. Hendrickson, and S. Le Grice (1995)
Science 267, 96-99
   Abstract »    PDF »
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor.
L. Kohlstaedt, J Wang, J. Friedman, P. Rice, and T. Steitz (1992)
Science 256, 1783-1790
   Abstract »    PDF »
Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase.
J. Davies 2nd, Z Hostomska, Z Hostomsky, Jordan SR, and D. Matthews (1991)
Science 252, 88-95
   Abstract »    PDF »
Molecular targets for AIDS therapy.
H Mitsuya, R Yarchoan, and S Broder (1990)
Science 249, 1533-1544
   Abstract »    PDF »
HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals.
B. Walker, C Flexner, T. Paradis, T. Fuller, M. Hirsch, R. Schooley, and B Moss (1988)
Science 240, 64-66
   Abstract »    PDF »
Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli.
W. Farmerie, D. Loeb, N. Casavant, C. Hutchison 3rd, M. Edgell, and R Swanstrom (1987)
Science 236, 305-308
   Abstract »    PDF »
Developmental Therapeutics and the Acquired Immunodeficiency Syndrome.
V. T. DEVITA Jr., S. BRODER, A. S. FAUCI, J. A. KOVACS, and B. A. CHABNER (1987)
Ann Intern Med 106, 568-581
   Abstract »    PDF »
Characterization and clinical association of antibody inhibitory to HIV reverse transcriptase activity.
J Laurence, A Saunders, and J Kulkosky (1987)
Science 235, 1501-1504
   Abstract »    PDF »
New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM).
P. Kanki, F Barin, S M'Boup, J. Allan, J. Romet-Lemonne, R Marlink, M. McLane, T. Lee, B Arbeille, F Denis, et al. (1986)
Science 232, 238-243
   Abstract »    PDF »
Physical Mapping of HIV Reverse Transcriptase to the 5' End of RNA Primers.
J. J. DeStefano, J. V. Cristofaro, S. Derebail, W. P. Bohlayer, and M. J. Fitzgerald-Heath (2001)
J. Biol. Chem. 276, 32515-32521
   Abstract »    Full Text »    PDF »
Functional Characterization of Chimeric Reverse Transcriptases with Polypeptide Subunits of Highly Divergent HIV-1 Group M and O Strains.
L. Menendez-Arias, A. Abraha, M. E. Quinones-Mateu, A. Mas, M.-J. Camarasa, and E. J. Arts (2001)
J. Biol. Chem. 276, 27470-27479
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)